Sphenopalatine ganglion stimulation (SPG-Stim) for ischemic stroke, starting 8–24 h after onset and continuing through five days in a pooled analysis of two recent, randomized, sham-controlled trials, improved outcome of acute ischemic stroke patients with confirmed cortical involvement. As a neuromodulatory therapy, SPG-Stim differs substantially from existing pharmacologic (lytic and antiplatelets) and device (endovascular thrombectomy) acute ischemic stroke treatments.
Aim
Focused review of SPG anatomy, physiology, and neurovascular and neurobiologic mechanisms of action mediating benefit of SPG-Stim in acute ischemic stroke.
Summary of review
Located posterior to the maxillary sinus, the SPG is the main source of parasympathetic innervation to the anterior circulation. Preclinical and human studies delineate four distinct mechanisms of action by which the SPG-Stim may confer benefit in acute ischemic stroke: (1) collateral vasodilation and enhanced cerebral blood flow, mediated by release of neurotransmitters with vasodilatory effects, nitric oxide, and acetylcholine, (2) stimulation frequency- and intensity-dependent stabilization of the blood–brain barrier, reducing edema (3) direct acute neuroprotection from activation of the central cholinergic system with resulting anti-inflammatory, anti-apoptotic, and anti-excitatory effects; and (4) neuroplasticity enhancement from enhanced central cholinergic and adrenergic neuromodulation of cortical networks and nitrous oxide release stimulating neurogenesis.
Conclusion
The benefit of SPG-Stim in acute ischemic stroke is likely conferred not only by potent collateral augmentation, but also blood–barrier stabilization, direct neuroprotection, and neuroplasticity enhancement. Further studies clarifying the relative contribution of these mechanisms and the stimulation protocols that maximize each may help optimize SPG-Stim as a therapy for acute ischemic stroke.
Bornstein NM, Saver JL, Diener HC, Gorelick PB, Shuaib A, Solberg Y, et al. Sphenopalatine Ganglion Stimulation to Augment Cerebral Blood Flow. Stroke. 2019: STROKEAHA118024582.
2.
BornsteinNMSaverJLDienerHCGorelickPBShuaibASolbergY, et al.An injectable implant to stimulate the sphenopalatine ganglion for treatment of acute ischaemic stroke up to 24 h from onset (ImpACT-24B): an international, randomised, double-blind, sham-controlled, pivotal trial. Lancet2019; 394: 219–29.
3.
Gibbins I. Peripheral autonomic pathways. In: Mai JK PG, (ed.), The Human Nervous System. Vol. 3, Waltham, MA: Academic Press; 2011. p. 134–89.
4.
GoadsbyPJ. Autonomic nervous system control of the cerebral circulation. Handb Clin Neurol2013; 117: 193–201.
5.
RobbinsMSRobertsonCEKaplanEAilaniJCharlestonLtKuruvillaD, et al.The sphenopalatine ganglion: anatomy, pathophysiology, and therapeutic targeting in headache. Headache2016; 56: 240–258.
6.
BinfalahMAlghawiEShoshaEAlhillyABakhietM. Sphenopalatine ganglion block for the treatment of acute migraine headache. Pain Res Treat2018; 2018: 2516953–2516953.
7.
LvXWuZLiY. Innervation of the cerebral dura mater. Neuroradiol J2014; 27: 293–298.
AttwellDBuchanAMCharpakSLauritzenMMacvicarBANewmanEA. Glial and neuronal control of brain blood flow. Nature2010; 468: 232–243.
14.
Willis T and Feindel W. The anatomy of the brain and nerves. Special ed. Birmingham, Ala.: Classics of Medicine Library, 1978. xvi, 2, 192 p., 14 leaves of plates (4 fold.).
15.
Lavrent'evaNBMcHedlishviliGIPlechkovaEK. [Cholinesterase distribution and activity in the nervous structures of the pial arteries (a histochemical study)]. Biull Eksp Biol Med1968; 66: 110–113.
16.
AyajikiKFujiokaHShinozakiKOkamuraT. Effects of capsaicin and nitric oxide synthase inhibitor on increase in cerebral blood flow induced by sensory and parasympathetic nerve stimulation in the rat. J Appl Physiol2005; 98: 1792–1798.
17.
GoadsbyPJ. Sphenopalatine ganglion stimulation increases regional cerebral blood flow independent of glucose utilization in the cat. Brain Res1990; 506: 145–148.
18.
GoadsbyPJUddmanREdvinssonL. Cerebral vasodilatation in the cat involves nitric oxide from parasympathetic nerves. Brain Res1996; 707: 110–118.
19.
HenningerNFisherM. Stimulating circle of Willis nerve fibers preserves the diffusion-perfusion mismatch in experimental stroke. Stroke2007; 38: 2779–2786.
20.
LeviHSchoknechtKPragerOChassidimYWeissbergISerlinY, et al.Stimulation of the sphenopalatine ganglion induces reperfusion and blood-brain barrier protection in the photothrombotic stroke model. PLoS One2012; 7: e39636–e39636.
21.
SeylazJHaraHPinardEMraovitchSMacKenzieETEdvinssonL. Effect of stimulation of the sphenopalatine ganglion on cortical blood flow in the rat. J Cereb Blood Flow Metab1988; 8: 875–878.
22.
TodaNAyajikiKTanakaTOkamuraT. Preganglionic and postganglionic neurons responsible for cerebral vasodilation mediated by nitric oxide in anesthetized dogs. J Cereb Blood Flow Metab2000; 20: 700–708.
23.
TodaNTanakaTAyajikiKOkamuraT. Cerebral vasodilatation induced by stimulation of the pterygopalatine ganglion and greater petrosal nerve in anesthetized monkeys. Neuroscience2000; 96: 393–398.
24.
YarnitskyDLorianAShalevAZhangZDTakahashiMAgbaje-WilliamsM, et al.Reversal of cerebral vasospasm by sphenopalatine ganglion stimulation in a dog model of subarachnoid hemorrhage. Surg Neurol2005; 64: 5–11.
25.
BorsodyMKSacristanE. Facial nerve stimulation as a future treatment for ischemic stroke. Brain Circ2016; 2: 164–177.
26.
TakahashiMZhangZDMacdonaldRL. Sphenopalatine ganglion stimulation for vasospasm after experimental subarachnoid hemorrhage. J Neurosurg2011; 114: 1104–1109.
27.
DiansanSShifenZZhenGHemingWXiangruiW. Resection of the nerves bundle from the sphenopalatine ganglia tend to increase the infarction volume following middle cerebral artery occlusion. Neurol Sci2010; 31: 431–435.
28.
BridgesTJClarkKYahrMD. Plethsymographic studies of the cerebral circulation: evidence for cranial nerve vasomotor activity. J Clin Invest1958; 37: 763–772.
29.
SanchezOGarciaACastro-PradoFPerezMLara-EstradaRRamirez-MezaM, et al.Facial nerve stimulation in normal pigs and healthy human volunteers: transitional development of a medical device for the emergency treatment of ischemic stroke. J Transl Med2018; 16: 27–27.
30.
SaverJLKharaishviliNJanelidzeTBeridzeMZarquaNSolbergY, et al.Refined sphenopalatine ganglion stimulator placement and intensity setting to augment blood flow and neurologic function. Stroke2019; 50: 3512–3518.
31.
AbdullahiWTripathiDRonaldsonPT. Blood-brain barrier dysfunction in ischemic stroke: targeting tight junctions and transporters for vascular protection. Am J Physiol Cell Physiol2018; 315: C343–C356.
32.
LiYZhongWJiangZTangX. New progress in the approaches for blood-brain barrier protection in acute ischemic stroke. Brain Res Bull2019; 144: 46–57.
ScalzoFAlgerJRHuXSaverJLDaniKAMuirKW, et al.Multi-center prediction of hemorrhagic transformation in acute ischemic stroke using permeability imaging features. Magn Reson Imaging2013; 31: 961–969.
35.
SifatAEVaidyaBAbbruscatoTJ. Blood-brain barrier protection as a therapeutic strategy for acute ischemic stroke. AAPS J2017; 19: 957–972.
36.
FrederiksenSDHaanesKAWarfvingeKEdvinssonL. Perivascular neurotransmitters: regulation of cerebral blood flow and role in primary headaches. J Cereb Blood Flow Metab2019; 39: 610–632.
37.
OliveraGCRenXVodnalaSKLuJCoppoLLeepiyasakulchaiC, et al.Nitric oxide protects against infection-induced neuroinflammation by preserving the stability of the blood-brain barrier. PLoS Pathog2016; 12: e1005442–e1005442.
38.
SchmidtRFTheofanisTNLangMJStricsekGPLinRLebrunA, et al.Sphenopalatine ganglion stimulation is a reversible and frequency-dependent modulator of the blood-brain barrier. Brain Res2019; 1718: 231–241.
39.
DelepineLAubineauP. Plasma protein extravasation induced in the rat dura mater by stimulation of the parasympathetic sphenopalatine ganglion. Exp Neurol1997; 147: 389–400.
40.
Vorasayan P, Bevers MB, Beslow LA, Sze G, Molyneaux BJ, Hinson HE, et al. Intravenous Glibenclamide Reduces Lesional Water Uptake in Large Hemispheric Infarction. Stroke. 2019:STROKEAHA119026036.
41.
Van BockstaeleEJPeoplesJTeleganP. Efferent projections of the nucleus of the solitary tract to peri-locus coeruleus dendrites in rat brain: evidence for a monosynaptic pathway. J Comp Neurol1999; 412: 410–428.
42.
ChiluwalANarayanRKChaungWMehanNWangPBoutonCE, et al.Neuroprotective effects of trigeminal nerve stimulation in severe traumatic brain injury. Sci Rep2017; 7: 6792–6792.
43.
MerrillCAJonssonMAMinthonLEjnellHC-son SilanderHBlennowK, et al.Vagus nerve stimulation in patients with Alzheimer's disease: additional follow-up results of a pilot study through 1 year. J Clin Psychiatry2006; 67: 1171–1178.
44.
NerenDJohnsonMDLegonWBachourSPLingGDivaniAA. Vagus nerve stimulation and other neuromodulation methods for treatment of traumatic brain injury. Neurocrit Care2016; 24: 308–319.
45.
Ter HorstGJAscending projections to solitary tract nucleus. In: BarracoRA(ed). Nucleus of the solitary tract, Boca Rato, FL: CRC Press, Inc, 1994.
46.
AyISorensenAGAyH. Vagus nerve stimulation reduces infarct size in rat focal cerebral ischemia: an unlikely role for cerebral blood flow. Brain Res2011; 1392: 110–115.
47.
Sternberg Z, Schaller B. Central Noradrenergic Agonists in the Treatment of Ischemic Stroke-an Overview. Transl Stroke Res2020; 11(2): 165–84.
48.
KrahlSEClarkKBSmithDCBrowningRA. Locus coeruleus lesions suppress the seizure-attenuating effects of vagus nerve stimulation. Epilepsia1998; 39: 709–714.
49.
MarrosuFSerraAMaleciAPulighedduMBiggioGPigaM. Correlation between GABA(A) receptor density and vagus nerve stimulation in individuals with drug-resistant partial epilepsy. Epilepsy Res2003; 55: 59–70.
50.
Ben-MenachemEHambergerAHednerT, et al.Effects of vagus nerve stimulation on amino acids and other metabolites in the CSF of patients with partial seizures. Epilepsy Res1995; 20: 221–227.
51.
LydenPDHedgesB. Protective effect of synaptic inhibition during cerebral ischemia in rats and rabbits. Stroke1992; 23: 1463–1469. discussion: 9–70.
52.
GolanovEVReisDJ. Neuroprotective electrical stimulation of cerebellar fastigial nucleus attenuates expression of periinfarction depolarizing waves (PIDs) and inhibits cortical spreading depression. Brain Res1999; 818: 304–315.
BerettaSVersaceACaroneDRivaMDell'EraVCuccioneE, et al.Cerebral collateral therapeutics in acute ischemic stroke: a randomized preclinical trial of four modulation strategies. J Cereb Blood Flow Metab2017; 37: 3344–3354.
55.
CramerSCWolfSLHPJrAdamsChenDDromerickAWDunningK, et al.Stroke recovery and rehabilitation research: issues, opportunities, and the National Institutes of Health StrokeNet. Stroke2017; 48: 813–819.
56.
MurphyTHCorbettD. Plasticity during stroke recovery: from synapse to behaviour. Nat Rev Neurosci2009; 10: 861–872.
57.
ConnerJMChibaAATuszynskiMH. The basal forebrain cholinergic system is essential for cortical plasticity and functional recovery following brain injury. Neuron2005; 46: 173–179.
58.
RamanathanDTuszynskiMHConnerJM. The basal forebrain cholinergic system is required specifically for behaviorally mediated cortical map plasticity. J Neurosci2009; 29: 5992–6000.
59.
HulseyDRHaysSAKhodaparastNRuizADasPRennakerRL2nd, et al.Reorganization of motor cortex by vagus nerve stimulation requires cholinergic innervation. Brain Stimul2016; 9: 174–181.
60.
ChenJZacharekAZhangCJiangHLiYRobertsC, et al.Endothelial nitric oxide synthase regulates brain-derived neurotrophic factor expression and neurogenesis after stroke in mice. J Neurosci2005; 25: 2366–2375.
61.
ZhuDYLiuSHSunHSLuYM. Expression of inducible nitric oxide synthase after focal cerebral ischemia stimulates neurogenesis in the adult rodent dentate gyrus. J Neurosci2003; 23: 223–229.
Bar-ShirAShemeshNNossin-ManorRCohenY. Late stimulation of the sphenopalatine-ganglion in ischemic rats: improvement in N-acetyl-aspartate levels and diffusion weighted imaging characteristics as seen by MR. J Magn Reson Imaging2010; 31: 1355–1363.
64.
CaponeFMiccinilliSPellegrinoGZolloLSimonettiDBressiF, et al.Transcutaneous vagus nerve stimulation combined with robotic rehabilitation improves upper limb function after stroke. Neural Plast2017; 2017: 7876507–7876507.
65.
DawsonJPierceDDixitAKimberleyTJRobertsonMTarverB, et al.Safety, feasibility, and efficacy of vagus nerve stimulation paired with upper-limb rehabilitation after ischemic stroke. Stroke2016; 47: 143–150.
66.
Bahr HosseiniMHouJBiksonMIacoboniMGornbeinJSaverJL. Central nervous system electrical stimulation for neuroprotection in acute cerebral ischemia: meta-analysis of preclinical studies. Stroke2019; 50: 2892–2901.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
